cobas® SARS-CoV-2 & Influenza A/B Test
4.5 (778) · € 21.99 · Auf Lager
Roche 09211101190 - McKesson Medical-Surgical
Roche gets FDA EUA status for cobas SARS-CoV-2 & Influenza A/B Test
Roche su LinkedIn: SARS-CoV-2 & Flu A/B Rapid Antigen Test
What's New for RCM? Updates on Coding for COVID-19 Testing - Journal of Urgent Care Medicine
Clinical Performance of the cobas Liat SARS-CoV-2 & Influenza A/B Assay in Nasal Samples
Aptamers as promising nanotheranostic tools in the COVID‐19 pandemic era - Dzuvor - 2022 - WIREs Nanomedicine and Nanobiotechnology - Wiley Online Library
FDA reports problems with Roche combo test for COVID-19 and flu - MassDevice
Roche Covid-19 and Influenza A/B Test Receives EUA
Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1
Multi-center nationwide comparison of seven serology assays reveals a SARS- CoV-2 non-responding seronegative subpopulation - eClinicalMedicine
